Collaborative machine learning-guided overall survival prediction of oral squamous cell carcinoma
Alabi, Rasheed Omobolaji; Elmusrati, Mohammed; Leivo, Ilmo; Almangush, Alhadi; Mäkitie, Antti A. (2024-12-31)
Huom!
Tiedosto avautuu julkiseksi: : 31.12.2025
Tiedosto avautuu julkiseksi: : 31.12.2025
Alabi, Rasheed Omobolaji
Elmusrati, Mohammed
Leivo, Ilmo
Almangush, Alhadi
Mäkitie, Antti A.
Taylor & Francis
31.12.2024
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi-fe2025031217504
https://urn.fi/URN:NBN:fi-fe2025031217504
Kuvaus
vertaisarvioitu
©2024 Taylor and Francis. This is an Accepted Manuscript of an article published by Taylor & Francis in Acta oto-laryngologica on 31 December 2024, available online: http://www.tandfonline.com/00016489.2024.2437012
©2024 Taylor and Francis. This is an Accepted Manuscript of an article published by Taylor & Francis in Acta oto-laryngologica on 31 December 2024, available online: http://www.tandfonline.com/00016489.2024.2437012
Tiivistelmä
Background
There is a lack of prognosticators of overall survival (OS) for Oral Squamous Cell Carcinoma (OSCC).
Objectives
We examined collaborative machine learning (cML) in estimating the OS of OSCC patients. The prognostic significance of the clinicopathological parameters was examined.
Methodology
Altogether, 9439 OSCC patients were extracted from the Surveillance, Epidemiology, and End Results database (US). Five ML models – voting ensemble, stacked ensemble, extreme gradient boosting, light boosting, and logistic regression were used to predict OS. Three of these ML algorithms were combined to form a cluster of cML models. The performance of the cML was compared with the best performing individual ML algorithm following model training.
Results
The performance accuracy of the voting ensemble, stacked ensemble, extreme gradient boosting, light boosting, and logistic regression models was 70.2%, 69.9%, 69.1%, 69.4%, and 69.5% respectively, following model training. When the voting ensemble model was compared with cML using temporal validation, the cML showed a comparable performance accuracy. The most significant prognostic factors were age of the patient at diagnosis, T stage, tumor grade, marital status, gender, primary site, surgery, N stage, radiotherapy, ethnicity, chemotherapy, and M stage.
Conclusions
cML appears to give reliability to the final prediction and thereby may mark a paradigm shift from model individualism to a more cooperative paradigm. This approach may aid in determining an enhanced individualized treatment for OSCC patients.
There is a lack of prognosticators of overall survival (OS) for Oral Squamous Cell Carcinoma (OSCC).
Objectives
We examined collaborative machine learning (cML) in estimating the OS of OSCC patients. The prognostic significance of the clinicopathological parameters was examined.
Methodology
Altogether, 9439 OSCC patients were extracted from the Surveillance, Epidemiology, and End Results database (US). Five ML models – voting ensemble, stacked ensemble, extreme gradient boosting, light boosting, and logistic regression were used to predict OS. Three of these ML algorithms were combined to form a cluster of cML models. The performance of the cML was compared with the best performing individual ML algorithm following model training.
Results
The performance accuracy of the voting ensemble, stacked ensemble, extreme gradient boosting, light boosting, and logistic regression models was 70.2%, 69.9%, 69.1%, 69.4%, and 69.5% respectively, following model training. When the voting ensemble model was compared with cML using temporal validation, the cML showed a comparable performance accuracy. The most significant prognostic factors were age of the patient at diagnosis, T stage, tumor grade, marital status, gender, primary site, surgery, N stage, radiotherapy, ethnicity, chemotherapy, and M stage.
Conclusions
cML appears to give reliability to the final prediction and thereby may mark a paradigm shift from model individualism to a more cooperative paradigm. This approach may aid in determining an enhanced individualized treatment for OSCC patients.
Kokoelmat
- Artikkelit [3050]